HilleVax (HLVX)
(Delayed Data from NSDQ)
$1.80 USD
-0.01 (-0.55%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
View All Zacks #1 Ranked Stocks
HilleVax, Inc. (HLVX) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $3.00 | $5.00 | $2.00 | 65.75% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for HilleVax, Inc. comes to $3.00. The forecasts range from a low of $2.00 to a high of $5.00. The average price target represents an increase of 65.75% from the last closing price of $1.81.
Analyst Price Targets (4 )
Broker Rating
HilleVax, Inc. currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on five recommendations.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 3.00 | 3.00 | 3.00 | 3.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 7/9/2024 | SVB Securities | David Risinger | Strong Buy | Hold |
| 7/9/2024 | Not Identified | Not Identified | Hold | Hold |
| 7/9/2024 | H.C. Wainwright & Co. | Matthew Caufield | Strong Buy | Hold |
| 7/8/2024 | Guggenheim Securities | Seamus Fernandez | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 3.00 |
| ABR (Last week) | 3.00 |
| # of Recs in ABR | 5 |
| Average Target Price | $3.00 |
| LT Growth Rate | NA |
| Industry | Medical - Biomedical and Genetics |
| Industry Rank by ABR | 79 of 253 |
| Current Quarter EPS Est: | -0.42 |
HLVX FAQs
HilleVax, Inc. (HLVX) currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for HilleVax, Inc. (HLVX) is $3.00. The current on short-term price targets is based on 4 reports.
The forecasts for HilleVax, Inc. (HLVX) range from a low of $2 to a high of $5. The average price target represents a increase of $66.67 from the last closing price of $1.80.
The current UPSIDE for HilleVax, Inc. (HLVX) is 66.67%
Based on short-term price targets offered by four analysts, the average price target for HilleVax, Inc. comes to $3.00. The forecasts range from a low of $2.00 to a high of $5.00. The average price target represents an increase of 65.75% from the last closing price of $1.81.